China Resources Pharmaceutical Group Limited (FRA:640)
Germany flag Germany · Delayed Price · Currency is EUR
0.5350
+0.0050 (0.94%)
At close: Apr 17, 2025, 10:00 PM CET

FRA:640 Statistics

Total Valuation

FRA:640 has a market cap or net worth of EUR 3.53 billion. The enterprise value is 15.88 billion.

Market Cap 3.53B
Enterprise Value 15.88B

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date Aug 25, 2025
Ex-Dividend Date May 28, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.82B

Valuation Ratios

The trailing PE ratio is 8.00.

PE Ratio 8.00
Forward PE n/a
PS Ratio 0.10
PB Ratio 0.27
P/TBV Ratio 1.53
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 36.03
EV / Sales 0.51
EV / EBITDA 8.84
EV / EBIT 10.66
EV / FCF n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.70.

Current Ratio 1.41
Quick Ratio 0.82
Debt / Equity 0.70
Debt / EBITDA 4.75
Debt / FCF n/a
Interest Coverage 5.30

Financial Efficiency

Return on equity (ROE) is 8.80% and return on invested capital (ROIC) is 4.65%.

Return on Equity (ROE) 8.80%
Return on Assets (ROA) 2.97%
Return on Invested Capital (ROIC) 4.65%
Return on Capital Employed (ROCE) 9.55%
Revenue Per Employee 469,027
Profits Per Employee 6,064
Employee Count 72,700
Asset Turnover 1.02
Inventory Turnover 6.30

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -4.46% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -4.46%
50-Day Moving Average 0.61
200-Day Moving Average 0.63
Relative Strength Index (RSI) 38.54
Average Volume (20 Days) 1,800

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:640 had revenue of EUR 34.10 billion and earned 440.83 million in profits. Earnings per share was 0.07.

Revenue 34.10B
Gross Profit 5.38B
Operating Income 1.59B
Pretax Income 1.45B
Net Income 440.83M
EBITDA 1.92B
EBIT 1.59B
Earnings Per Share (EPS) 0.07
Full Income Statement

Balance Sheet

The company has 2.17 billion in cash and 9.13 billion in debt, giving a net cash position of -6.96 billion.

Cash & Cash Equivalents 2.17B
Total Debt 9.13B
Net Cash -6.96B
Net Cash Per Share n/a
Equity (Book Value) 12.98B
Book Value Per Share 1.02
Working Capital 7.10B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 15.79%, with operating and profit margins of 4.65% and 1.30%.

Gross Margin 15.79%
Operating Margin 4.65%
Pretax Margin 4.24%
Profit Margin 1.30%
EBITDA Margin 5.64%
EBIT Margin 4.65%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 5.70%.

Dividend Per Share 0.03
Dividend Yield 5.70%
Dividend Growth (YoY) n/a
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 5.70%
Earnings Yield 12.50%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a